Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies.

J. Cloos, D. Niewerth, G. Jansen

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Original languageUndefined/Unknown
Title of host publicationResistance to proteasome inhibitors in cancer
Pages181-204
Publication statusPublished - 2014

Publication series

Name
Number7

Cite this

@inbook{864f29c8e9d04173b57ffa3f1a6f5417,
title = "Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies.",
author = "J. Cloos and D. Niewerth and G. Jansen",
year = "2014",
language = "Undefined/Unknown",
number = "7",
pages = "181--204",
booktitle = "Resistance to proteasome inhibitors in cancer",

}

Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies. / Cloos, J.; Niewerth, D.; Jansen, G.

Resistance to proteasome inhibitors in cancer. 2014. p. 181-204.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

TY - CHAP

T1 - Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies.

AU - Cloos, J.

AU - Niewerth, D.

AU - Jansen, G.

PY - 2014

Y1 - 2014

M3 - Chapter

SP - 181

EP - 204

BT - Resistance to proteasome inhibitors in cancer

ER -